Walgreens Free Cash Flow Yield vs Capex To Depreciation Analysis

WBA Stock

USD 8.71 0.27 3.01%

Walgreens Boots financial indicator trend analysis is more than just analyzing Walgreens Boots Alliance current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Walgreens Boots Alliance is a good investment. Please check the relationship between Walgreens Boots Free Cash Flow Yield and its Capex To Depreciation accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Free Cash Flow Yield vs Capex To Depreciation

Free Cash Flow Yield vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Walgreens Boots Alliance Free Cash Flow Yield account and Capex To Depreciation. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Walgreens Boots' Free Cash Flow Yield and Capex To Depreciation is -0.43. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Walgreens Boots Alliance, assuming nothing else is changed. The correlation between historical values of Walgreens Boots' Free Cash Flow Yield and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Walgreens Boots Alliance are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Free Cash Flow Yield i.e., Walgreens Boots' Free Cash Flow Yield and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.43

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Walgreens Boots' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Walgreens Boots Alliance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

The current year's Selling General Administrative is expected to grow to about 40.4 B, whereas Tax Provision is projected to grow to (1.6 B).

	2021	2022	2023	2024 (projected)
Gross Profit	28.3B	27.1B	31.1B	32.7B
Total Revenue	132.7B	139.1B	159.9B	167.9B

Gross Profit Total Revenue

Walgreens Boots fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Common Stock	Other Liab	Other Assets	Long Term Debt
Total Assets		0.92	0.7	0.95	0.41	0.89	0.89	0.91	-0.02	0.99	0.08	0.01	0.8	-0.5	0.96	0.59	0.93	-0.54	0.98	0.51	0.65	0.9	-0.84	0.85	0.56	0.49
Short Long Term Debt Total	0.92		0.51	0.88	0.2	0.97	0.99	0.8	-0.17	0.95	0.02	-0.14	0.62	-0.65	0.97	0.42	0.77	-0.68	0.97	0.32	0.75	0.78	-0.74	0.68	0.45	0.32
Other Current Liab	0.7	0.51		0.62	0.17	0.51	0.5	0.6	-0.07	0.71	0.31	-0.04	0.41	-0.42	0.64	0.26	0.71	-0.33	0.65	0.19	0.3	0.59	-0.5	0.84	0.51	0.2
Total Current Liabilities	0.95	0.88	0.62		0.41	0.82	0.87	0.94	-0.13	0.93	0.23	-0.11	0.87	-0.48	0.88	0.65	0.93	-0.63	0.95	0.53	0.8	0.97	-0.87	0.75	0.4	0.52
Total Stockholder Equity	0.41	0.2	0.17	0.41		0.15	0.12	0.57	0.47	0.3	-0.18	0.5	0.68	0.31	0.21	0.88	0.51	0.2	0.28	0.92	0.07	0.5	-0.56	0.16	0.2	0.83
Property Plant And Equipment Net	0.89	0.97	0.51	0.82	0.15		0.97	0.79	-0.25	0.93	0.05	-0.21	0.52	-0.75	0.95	0.37	0.69	-0.72	0.93	0.22	0.7	0.69	-0.61	0.68	0.54	0.16
Net Debt	0.89	0.99	0.5	0.87	0.12	0.97		0.78	-0.32	0.93	0.08	-0.28	0.57	-0.72	0.95	0.36	0.74	-0.75	0.95	0.21	0.79	0.75	-0.7	0.66	0.46	0.21
Retained Earnings	0.91	0.8	0.6	0.94	0.57	0.79	0.78		-0.04	0.88	0.21	0.0	0.84	-0.44	0.8	0.75	0.86	-0.58	0.87	0.61	0.7	0.91	-0.79	0.66	0.39	0.53
Cash	-0.02	-0.17	-0.07	-0.13	0.47	-0.25	-0.32	-0.04		-0.13	-0.36	0.99	0.18	0.63	-0.11	0.22	0.02	0.66	-0.12	0.58	-0.46	0.0	-0.12	-0.02	-0.17	0.6
Non Current Assets Total	0.99	0.95	0.71	0.93	0.3	0.93	0.93	0.88	-0.13		0.11	-0.1	0.72	-0.59	0.98	0.5	0.89	-0.62	0.99	0.39	0.67	0.86	-0.79	0.86	0.59	0.37
Non Currrent Assets Other	0.08	0.02	0.31	0.23	-0.18	0.05	0.08	0.21	-0.36	0.11		-0.37	0.05	-0.43	0.02	0.01	0.13	-0.46	0.09	-0.15	0.5	0.13	0.06	0.13	0.06	-0.27
Cash And Short Term Investments	0.01	-0.14	-0.04	-0.11	0.5	-0.21	-0.28	0.0	0.99	-0.1	-0.37		0.18	0.61	-0.08	0.23	0.04	0.65	-0.1	0.59	-0.44	0.01	-0.14	-0.03	-0.16	0.62
Net Receivables	0.8	0.62	0.41	0.87	0.68	0.52	0.57	0.84	0.18	0.72	0.05	0.18		-0.01	0.64	0.8	0.9	-0.23	0.74	0.79	0.56	0.94	-0.91	0.6	0.33	0.8
Common Stock Shares Outstanding	-0.5	-0.65	-0.42	-0.48	0.31	-0.75	-0.72	-0.44	0.63	-0.59	-0.43	0.61	-0.01		-0.61	0.01	-0.26	0.86	-0.58	0.3	-0.68	-0.28	0.1	-0.4	-0.37	0.4
Non Current Liabilities Total	0.96	0.97	0.64	0.88	0.21	0.95	0.95	0.8	-0.11	0.98	0.02	-0.08	0.64	-0.61		0.41	0.83	-0.61	0.99	0.33	0.65	0.8	-0.76	0.83	0.55	0.33
Inventory	0.59	0.42	0.26	0.65	0.88	0.37	0.36	0.75	0.22	0.5	0.01	0.23	0.8	0.01	0.41		0.63	-0.17	0.5	0.9	0.41	0.72	-0.65	0.32	0.19	0.79
Other Current Assets	0.93	0.77	0.71	0.93	0.51	0.69	0.74	0.86	0.02	0.89	0.13	0.04	0.9	-0.26	0.83	0.63		-0.36	0.89	0.6	0.59	0.95	-0.93	0.82	0.54	0.63
Other Stockholder Equity	-0.54	-0.68	-0.33	-0.63	0.2	-0.72	-0.75	-0.58	0.66	-0.62	-0.46	0.65	-0.23	0.86	-0.61	-0.17	-0.36		-0.64	0.13	-0.81	-0.48	0.29	-0.38	-0.13	0.23
Total Liab	0.98	0.97	0.65	0.95	0.28	0.93	0.95	0.87	-0.12	0.99	0.09	-0.1	0.74	-0.58	0.99	0.5	0.89	-0.64		0.41	0.72	0.88	-0.82	0.82	0.52	0.4
Total Current Assets	0.51	0.32	0.19	0.53	0.92	0.22	0.21	0.61	0.58	0.39	-0.15	0.59	0.79	0.3	0.33	0.9	0.6	0.13	0.41		0.19	0.64	-0.68	0.28	0.09	0.95
Short Term Debt	0.65	0.75	0.3	0.8	0.07	0.7	0.79	0.7	-0.46	0.67	0.5	-0.44	0.56	-0.68	0.65	0.41	0.59	-0.81	0.72	0.19		0.69	-0.54	0.36	0.18	0.16
Accounts Payable	0.9	0.78	0.59	0.97	0.5	0.69	0.75	0.91	0.0	0.86	0.13	0.01	0.94	-0.28	0.8	0.72	0.95	-0.48	0.88	0.64	0.69		-0.93	0.73	0.33	0.66
Common Stock	-0.84	-0.74	-0.5	-0.87	-0.56	-0.61	-0.7	-0.79	-0.12	-0.79	0.06	-0.14	-0.91	0.1	-0.76	-0.65	-0.93	0.29	-0.82	-0.68	-0.54	-0.93		-0.67	-0.35	-0.75
Other Liab	0.85	0.68	0.84	0.75	0.16	0.68	0.66	0.66	-0.02	0.86	0.13	-0.03	0.6	-0.4	0.83	0.32	0.82	-0.38	0.82	0.28	0.36	0.73	-0.67		0.66	0.29
Other Assets	0.56	0.45	0.51	0.4	0.2	0.54	0.46	0.39	-0.17	0.59	0.06	-0.16	0.33	-0.37	0.55	0.19	0.54	-0.13	0.52	0.09	0.18	0.33	-0.35	0.66		0.04
Long Term Debt	0.49	0.32	0.2	0.52	0.83	0.16	0.21	0.53	0.6	0.37	-0.27	0.62	0.8	0.4	0.33	0.79	0.63	0.23	0.4	0.95	0.16	0.66	-0.75	0.29	0.04

Click cells to compare fundamentals

Walgreens Boots Account Relationship Matchups

Walgreens Boots fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	87.2B	81.3B	90.1B	96.6B	111.1B	116.7B
Short Long Term Debt Total	40.1B	33.4B	35.5B	33.5B	38.6B	40.5B
Total Current Liabilities	27.1B	22.1B	22.6B	24.5B	28.2B	29.6B
Total Stockholder Equity	21.1B	23.8B	29.4B	20.0B	23.0B	12.2B
Property Plant And Equipment Net	35.1B	34.1B	33.0B	33.3B	38.2B	40.2B
Net Debt	39.6B	32.2B	34.1B	32.8B	37.7B	39.6B
Retained Earnings	34.2B	35.1B	37.8B	33.1B	38.0B	39.9B
Cash	516M	1.2B	1.4B	728M	837.2M	1.1B
Non Current Assets Total	69.1B	65.5B	73.2B	81.1B	93.3B	98.0B
Non Currrent Assets Other	(822M)	137M	287M	2.6B	2.9B	3.1B
Cash And Short Term Investments	516M	1.2B	2.5B	739M	849.9M	1.2B
Net Receivables	7.1B	5.7B	5.0B	5.4B	6.2B	6.5B
Common Stock Shares Outstanding	880.3M	866.4M	865.9M	863.2M	776.9M	807.2M
Liabilities And Stockholders Equity	87.2B	81.3B	90.1B	96.6B	111.1B	116.7B
Non Current Liabilities Total	39.0B	35.4B	37.1B	43.6B	50.1B	52.7B
Inventory	9.5B	8.2B	8.4B	8.3B	9.5B	5.2B
Other Current Assets	974M	799M	1.1B	1.1B	1.3B	1.4B
Other Stockholder Equity	(9.3B)	(9.2B)	(5.6B)	(10.1B)	(9.1B)	(8.6B)
Total Liab	66.0B	57.5B	59.7B	68.1B	78.4B	82.3B
Total Current Assets	18.1B	15.8B	16.9B	15.5B	17.8B	9.2B
Short Term Debt	6.0B	3.6B	3.3B	3.3B	3.8B	3.9B
Accounts Payable	14.5B	11.1B	11.3B	12.6B	14.5B	15.3B
Other Liab	3.8B	5.3B	5.0B	12.4B	14.3B	15.0B
Other Assets	660M	2.0B	1.7B	2.5B	2.9B	3.0B
Long Term Debt	12.2B	7.7B	10.6B	8.1B	9.4B	5.9B
Property Plant Equipment	33.4B	34.1B	33.0B	31.8B	36.5B	38.3B
Property Plant And Equipment Gross	35.1B	34.1B	33.0B	46.2B	53.1B	55.8B
Accumulated Other Comprehensive Income	(3.8B)	(2.1B)	(2.8B)	(3.0B)	(2.7B)	(2.6B)
Good Will	15.3B	12.4B	22.3B	28.2B	32.4B	34.0B
Treasury Stock	(19.1B)	(20.6B)	(20.6B)	(20.7B)	(18.6B)	(17.7B)
Intangible Assets	10.8B	9.9B	10.7B	13.6B	15.7B	16.5B
Net Tangible Assets	20.6B	1.5B	26.3B	(23.3B)	(21.0B)	(19.9B)
Deferred Long Term Liab	1.8B	1.5B	1.9B	1.4B	1.3B	1.6B
Long Term Investments	7.3B	7.0B	5.5B	3.5B	3.1B	4.8B
Short Long Term Debt	3.5B	1.3B	1.1B	918M	826.2M	784.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GM	General Motors
GM	General Motors
GOOG	Alphabet Inc Class C

Additional Information and Resources on Investing in Walgreens Stock

When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:

How To Invest In Walgreens

Details

Is Walgreens Stock a good investment?

Details

What is Walgreens Boots' Net Worth?

Details

Largest Consumer Staples Distribution & Retail Companies

View

Largest Consumer Staples Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.915

Dividend Share

1.46

Earnings Share

(6.74)

Revenue Per Share

168.626

Quarterly Revenue Growth

0.026

The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Walgreens Free Cash Flow Yield vs Capex To Depreciation Analysis

Free Cash Flow Yield vs Capex To Depreciation

Free Cash Flow Yield vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Capex To Depreciation

Walgreens Boots fundamental ratios Correlations

Walgreens Boots Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Walgreens Boots fundamental ratios Accounts

Also Currently Popular

Additional Information and Resources on Investing in Walgreens Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Cash
Total Liab	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Liabilities Total
Total Liab	+ 0.98	Total Assets

Common Stock	- 0.93	Accounts Payable
Common Stock	- 0.93	Other Current Assets
Common Stock	- 0.91	Net Receivables
Common Stock	- 0.87	Total Current Liabilities
Common Stock	- 0.84	Total Assets
Common Stock	- 0.82	Total Liab